TrialThe pharmacogenomics journal2020

Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizers.

Sang Won Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.